METABOLIC RESEARCH · CANADA
Eloralintide in Canada: Amylin Research Peptide Guide + Janoshik COA
Eloralintide is one of the newest compounds in amylin-pathway metabolic research. This guide explains what it is, why researchers are interested in it, and what the independent lab test shows for our 10mg batch.
What is amylin research?
Amylin is a hormone co-released with insulin and studied for its role in satiety, gastric emptying and energy balance. Amylin agonists are investigated alone and alongside incretin compounds like Tirzepatide.
Why Eloralintide is getting attention
- Receptor-selective amylin agonism
- Early-satiety signaling research
- Lean mass preservation (in animal studies)
- Minimal CTR activation, studied for reduced GI effects
- Potential combination research with Tirzepatide (studies ongoing)
Independent test result
Our batch was tested by Janoshik Analytical (Task #211840, July 2026): 9.47 mg measured, 99.820% purity. See the full report on our Lab Reports page.
Ordering in Canada
Eloralintide 10mg ships from Toronto. Details on rates and timing are on our Shipping Policy. For background on related compounds, read GLP-1 Research: Tirzepatide vs Retatrutide.
Disclaimer: Research compounds are intended strictly for in-vitro laboratory and research use only. They are not intended for human consumption, therapeutic use, or diagnostic applications.
RELATED RESEARCH COMPOUNDS
Featured in this article
CONTINUE READING
October 23, 2026
Are Peptides Legal in Canada? What Research Use Actually Means
Health Canada regulates injectable peptides as prescription drugs. Here is what that means for research materials, and what a research-use label does not change.
October 23, 2026
Research Peptide Lab Safety: Handling, PPE and Disposal in Canada
Research peptides belong in a laboratory workflow: PPE, ventilation, documented handling and proper disposal. A practical safety overview for Canadian labs.